Coresys está orgulloso de anunciar que el próximo 25 de mayo va a participar en la Sociedad Ecuatoriana de Anesteología (SEA) mediante una presentación. https://sea.org.ec/ La presentación, programada para el jueves 25 de mayo a las 14:00, se espera que atraiga la atención de los asistentes, quienes tendrán la oportunidad de conocer de primera mano […]
Coresys Health participated in the Mobile World Congress in Barcelona on 1st and 2nd March. The company expressed their appreciation to all those who visited their booth during the event. They were pleased to have the opportunity to showcase their latest technologies and solutions that are designed to transform the healthcare industry. The company engaged […]
4YFN is the startup event of the world’s largest exhibition for the mobile industry. We are happy to announce that CoreSys health will have a stand in the event. The event will be held in the 1st and 2nd of March in Barcelona. Send us an email and program a meeting with us already now.
After receiving the award for the best technological and innovation project in this year’s “Premi Creatic”, “La Vanguardia” has released an extended review of the event with more information of the company. The whole article can be read in this link.
CoreSys Health participated on November 24th as one of the ten preselected companies to win the “Premio Creatic” organized by the Tecnocampus Mataró Start-up hub. The jury unanimously awarded Coresys Health for the best technological and innovation project. A more extended review can be read (in Spanish) on this national newspaper. Another review of the […]
Coresys Health is excited to announce that we will be attending Arab Health, one of the largest healthcare exhibitions and congresses in the world. The event will take place from January 30 to February 2nd, 2023 at the Dubai World Trade Centre in Dubai, United Arab Emirates. At Arab Health, Coresys Health will have the […]
Last June, Coresys obtained the certification “Registro de entidades innovadoras” which is a recognition given to small innovative companies with a high level of I+D development.